1. Home
  2. CAVA vs BRKR Comparison

CAVA vs BRKR Comparison

Compare CAVA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$58.93

Market Cap

6.8B

ML Signal

HOLD

Logo Bruker Corporation

BRKR

Bruker Corporation

HOLD

Current Price

$47.47

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAVA
BRKR
Founded
2006
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.3B
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
CAVA
BRKR
Price
$58.93
$47.47
Analyst Decision
Buy
Buy
Analyst Count
19
13
Target Price
$78.84
$49.42
AVG Volume (30 Days)
3.3M
1.9M
Earning Date
11-04-2025
02-12-2026
Dividend Yield
N/A
0.42%
EPS Growth
151.16
N/A
EPS
1.16
N/A
Revenue
$1,132,074,000.00
$3,438,900,000.00
Revenue This Year
$24.00
$3.55
Revenue Next Year
$20.42
$1.49
P/E Ratio
$50.62
N/A
Revenue Growth
23.93
6.10
52 Week Low
$43.41
$28.53
52 Week High
$144.49
$64.64

Technical Indicators

Market Signals
Indicator
CAVA
BRKR
Relative Strength Index (RSI) 60.47 56.53
Support Level $51.52 $47.52
Resistance Level $62.16 $48.73
Average True Range (ATR) 2.10 1.56
MACD 0.51 -0.09
Stochastic Oscillator 67.18 66.29

Price Performance

Historical Comparison
CAVA
BRKR

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: